z-logo
open-access-imgOpen Access
The Effect of Colchicine on Thyroid Eye Disease: A Case Report
Author(s) -
Ali Saklamaz,
Handan Bekdemir,
Murat Uyar,
Murat Yalçın,
Halida Mammadova,
Muammer Karadeniz
Publication year - 2015
Publication title -
turkish journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.111
H-Index - 5
ISSN - 1301-2193
DOI - 10.4274/tjem.2926
Subject(s) - medicine , colchicine , dermatology , thyroid , thyroid disease , optometry , ophthalmology
Thyroid eye disease (TED) is the most common extrathyroidal manifestation of Graves’ disease (GD). Corticosteroids are mostly used drug for this complication. Can colchicine be used for the treatment of Graves’ ophthalmopathy (GO)? A 49-year-old female, who suffered hyperthyroidism for 5 years, was admitted to our clinic for GO. Although the euthyroidism was achieved, there was no improvement in orbitopathy. Because of the patient’s condition, we could not prescribe corticosteroids to our patient. TED improved after 3 months of colchicine treatment and the patient was found to be satisfied with her new appearance. No side effects related with colchicine treatment were observed. Colchicine can be used as an effective and safe drug in GO

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom